CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis.
Michelle NaughtonJill MoffatGeorge EleftheriadisNira de la Vega GallardoAndrew YoungJohn FalconerKristen HawkinsBen PearsonBernard PerbalAndrew HoganPaul MoynaghSam LovelessNeil P RobertsonBruno GranRachael KeeStella HughesGavin McDonnellOwain HowellDenise C FitzgeraldPublished in: Journal of neuroinflammation (2020)
This investigation provides the first comprehensive profile of CCN3 expression in MS and provides rationale to determine if CCN3 contributes to neuroimmunological functions in the CNS.